Antibody-drug conjugates for cancer therapy
Antibody - drug conjugates (ADCs) are drugs designed to target specific anti-cancer treatment. ADCs are immunoconjugates comprised of a monoclonal antibody attached to cytotoxic drug via a chemical linker. ADCs utilize monoclonal antibodies (mAbs) to specifically bind tumor-associated target antigen...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Polish Pharmaceutical Society,
2021-11-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|